Canada’s Health Regulators Urged to Make PAH Therapies Accessible Through Public Funding
More than 2,000 letters urge Canadian health authorities to make all pulmonary arterial hypertension (PAH) therapies available through public funding so that new life-extending medications are accessible to all who need them. The letters were signed by PAH patients, their caregivers, family members, and friends and will be delivered to…